- 首頁
- App 分析
- Synergy Surgeon2
- Synergy Surgeon2 Vs. Arthrex Rep
Synergy Surgeon2 與 Arthrex Rep 使用情況與統計
The Synergy Surgeon Application 2.0 from Arthrex enables surgeons to download digital stills from the Arthrex Synergy system or upload stills from a device for presenting and archiving. A user-friendly interface allows annotations to be added to the digital stills enabling an educational presentation to the patient. The application includes a report generator in which website links and selected digital stills can be added and sent to a referring physician or the patient directly.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
The Arthrex Rep App is a sales enablement tool developed for Arthrex global agency sales representatives.
About Arthrex:
Arthrex is a global leader in multispecialty minimally invasive surgical technology, scientific research, manufacturing and medical education. Arthrex pioneered the field of arthroscopy and sports medicine and develops more than 1,000 new products and related procedures annually to advance minimally invasive orthopedic surgery, trauma, spine, cardiothoracic, orthobiologics and arthroplasty innovation worldwide. Arthrex also specializes in the latest 4K multispecialty surgical visualization and OR integration technology solutions.
Arthrex continues to experience unprecedented growth and demand for its products throughout the world; however, we remain a privately held company with a family business culture committed to delivering uncompromising quality to the health care professionals (HCPs) who use our products, and ultimately, the millions of patients whose lives we impact.
We invite you to learn more about Arthrex and the positive contributions we are making to medicine and the communities we serve.
- Apple App Store
- 免費版
- 醫療
商店排名
- -
Synergy Surgeon2與 Arthrex Rep 比較排名
比較過去 28 天的 Synergy Surgeon2 排名趨勢與 Arthrex Rep
排名
無可用數據
各國 Synergy Surgeon2 vs. Arthrex Rep 排名比較
比較過去 28 天的 Synergy Surgeon2 排名趨勢與 Arthrex Rep
無可顯示數據
使用我們的免費試用版,與所有網站進行比較
Synergy Surgeon2 VS.
Arthrex Rep
12月 24, 2024